Bertrand Lebouché, MD, PhD is a HIV and HCV Primary Care specialist at the Chronic Viral Illness Service of the McGill University Health Centre (MUHC)
An Associate Professor of Family Medicine at McGill University (Montreal, Canada), and a scientist conducting patient-oriented clinical research in HIV. Dr. Lebouché completed his medical training in Lille and Lyon, France. In 2010, he obtained a PhD specialising in Theology at Laval University (Québec, Canada) followed by postdoctoral training at McGill University.
More recently, he has invested in the development of innovative patient-centred tools to improve the care of people living with HIV within the field of mHealth. With Kim Engler PhD, he is leading a research program with investigators from across Canada and France, to develop, validate and implement a new electronically administered patient-reported outcome measure (e-PROM) for use in routine HIV care, to detect and help manage barriers to antiretroviral therapy adherence.
To administer this e-PROM, with David Lessard, PhD and Yuanchao Ma, engineer, he is adapting a patient-conceived smartphone app (Opal) for HIV care, in collaboration with Tarek Hijal, MD, John Kildea, PhD and Jamil Asselah, MD. Opal is currently in use at the Cedars Cancer Centre (MUHC). Dr. Lebouché and his team are also piloting Opal to monitor COVID-19 patients remotely.
